Skip to main content


We gratefully acknowlege the following organizations for their funding/support for our research:

Our active grants include:

  • Shi-Yuan Cheng, PhD, PI 
    • NIH/NINDS: 1R01NS115403-01A1
    • Role of Protein Methylation in Cell Mitosis and Glioblastoma
  • Shi-Yuan Cheng, PhD, PI 
    • NIH: 1R01NS125318-01A1
    • Targeting RNA Splicing in Glioma
  • Shi-Yuan Cheng, PhD, PI 
    • NIH, NINDS: R21, NS126819
    • Cysteine Depletion-induced Ferroptosis as a Therapeutic Vulnerability in Glioblastoma Temozolomide Resistance
  • Shi-Yuan Cheng, PhD, PI 
    • NIH, NINDS: R21, NS122375
    • Target ATG4B to Treat Glioblastoma
  • Deanna Marie Tiek, PhD, PI 
    • NIH/NCI: K99
    • Ferroptosis in drug resistant glioma
  • Deanna Marie Tiek, PhD, PI 
    • DOD: W81XWH-22-1-0373
    • Targeting Chromothripsis in Malignant Glioma
  • Xiao Song, PhD, PI 
    • DOD: W81XWH-22-1-0374
    • Targeting an RNA Binding Protein Network in Glioblastoma by Decoy RNA Oligonucleotides

Our recent grants include:

  • Shi-Yuan Cheng, PhD, PI 
    • NIH/NINDS: 1R01NS095634
    • Autophagy Regulation of Glioblastoma Tumorigenesis and Responses to Therapy
  • Shi-Yuan Cheng, PhD, Multi-PI, (MPI: Lesniak, M. and James, C.D.)
    • P50 CA221747-01A1 
    • Enhancing GBM Cytotoxic Therapy Through Inhibition of Key Autophagy Mediator ATG4B
  • Shi-Yuan Cheng, PhD, PI
    • NIH/NINDS: R01NS093843
    • Glioblastoma Phenotype Modulation through miRNA Control of Wnt Signaling
  • Namratha Sastry, BS
    • NIH/NCI: 1F31CA232630-01
    • Novel Roles of LY6K in Glioblastoma Tumorigenesis